Douglas A. Treco - Apr 1, 2023 Form 4 Insider Report for Inozyme Pharma, Inc. (INZY)

Role
CEO, Director
Signature
/s/ Douglas Treco
Stock symbol
INZY
Transactions as of
Apr 1, 2023
Transactions value $
$0
Form type
4
Date filed
4/4/2023, 04:05 PM
Previous filing
Jun 14, 2022
Next filing
Jun 9, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INZY Stock option (right to buy) Award $0 +800K $0.00 800K Apr 1, 2023 Common stock 800K $5.73 Direct F1, F2
transaction INZY Restricted stock units Award $0 +100K $0.00 100K Apr 1, 2023 Common stock 100K Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The exercise price represents the closing price of the Issuer's common stock on March 31, 2023.
F2 The option was granted on April 1, 2023 and is scheduled to vest in equal monthly installments until the fourth anniversary of the grant date.
F3 The restricted stock units were granted on April 1, 2023. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. The restricted stock units vest in equal annual installments on each anniversary of the grant date until the fourth anniversary of the grant date.